Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on October 8, 2008
J Am Soc Nephrol 19: 2262-2271, 2008
© 2008 American Society of Nephrology
doi: 10.1681/ASN.2007111199

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2007111199v1
19/12/2262    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Luks, A. M.
Right arrow Articles by Swenson, E. R.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Luks, A. M.
Right arrow Articles by Swenson, E. R.

Brief Reviews

Chronic Kidney Disease at High Altitude

Andrew M. Luks*, Richard J. Johnson{dagger} and Erik R. Swenson*,{ddagger}

* Division of Pulmonary and Critical Care Medicine, University of Washington, and {ddagger} Division of Pulmonary and Critical Care Medicine, VA Puget Sound Health Care System Seattle, Washington; and {dagger} Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado

Correspondence: Dr. Erik R. Swenson, Pulmonary and Critical Care Medicine, VA Puget Sound Health Care System, University of Washington, 1660 South Columbian Way, Seattle, WA 98108. Phone: 206-764-2668; Fax: 206-764-2659; E-mail: eswenson{at}u.washington.edu

With a prevalence of 10 to 11% in the general population, it is likely that many patients with chronic kidney disease will visit or reside in mountainous areas. Little is known, however, about whether short- or long-duration, high-altitude exposure poses a risk in this patient population. Given that many areas of the kidney are marginally oxygenated even at sea level and that kidney disease may result in further renal hypoxia and hypoxia-associated renal injury, there is concern that high altitude may accelerate the progression of chronic kidney disease. In this review, we address how chronic kidney disease and its management is affected at high altitude. We postulate that arterial hypoxemia at high altitude poses a risk of faster disease progression in those with preexisting kidney disease. In addition, we consider the risks of developing acute altitude illness in patients with chronic kidney disease and the appropriate use of medications for the prevention and treatment of these problems.







HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP